Ibrahim El‐Serafi
- Co-authors
- Moustapha HassanManuchehr Abedi‐ValugerdiHeba AsemFei YeJonas MattssonMamoun MuhammedKhalid M. Abu–SalahÅsa Barrefelt
- Topics
- Pharmacogenetics and Drug Metabolism (8 papers)Hematopoietic Stem Cell Transplantation (7 papers)Carcinogens and Genotoxicity Assessment (4 papers)
- Cited by
- BiomaterialsPharmacologyOncology
- Journals
- BloodPLoS ONEBiomaterials
- Partner nations
- SwedenUnited Arab EmiratesEgypt
In The Last Decade
Ibrahim El‐Serafi
29 papers receiving 584 citations
Peers
Comparison fields: 5 of 88
- Biomedical Engineering 178
- Oncology 158
- Molecular Biology 150
- Biomaterials 147
- Immunology 68
Countries citing papers authored by Ibrahim El‐Serafi
This map shows the geographic impact of Ibrahim El‐Serafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim El‐Serafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim El‐Serafi more than expected).
Fields of papers citing papers by Ibrahim El‐Serafi
This network shows the impact of papers produced by Ibrahim El‐Serafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim El‐Serafi. The network helps show where Ibrahim El‐Serafi may publish in the future.
Co-authorship network of co-authors of Ibrahim El‐Serafi
This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim El‐Serafi. A scholar is included among the top collaborators of Ibrahim El‐Serafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim El‐Serafi. Ibrahim El‐Serafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 21 | |
| 6 | 8 | |
| 7 | 23 | |
| 8 | 76 | |
| 9 | 11 | |
| 10 | 8 | |
| 11 | 16 | |
| 12 | 26 | |
| 13 | 24 | |
| 14 | 30 | |
| 15 | 8 | |
| 16 | 176 | |
| 17 | 4 | |
| 18 | 11 | |
| 19 | 7 | |
| 20 | 16 |
About Ibrahim El‐Serafi
Ibrahim El‐Serafi is a scholar working on Pharmacology, Hematology and Rehabilitation, having authored 31 papers that have together received 593 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Carcinogens and Genotoxicity Assessment (4 papers). The work is most often cited by research in Biomaterials (147 citations), Pharmacology (56 citations) and Oncology (158 citations). Ibrahim El‐Serafi has collaborated with scholars based in Sweden, United Arab Emirates and Egypt. Frequent co-authors include Moustapha Hassan, Manuchehr Abedi‐Valugerdi, Heba Asem, Fei Ye, Jonas Mattsson, Mamoun Muhammed, Khalid M. Abu–Salah, Åsa Barrefelt, Ahmed T. El‐Serafi and Salman Alrokayan. Their work appears in journals such as Blood, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.